MoonLake Immunotherapeutics (MLTX) Earnings Date & Reports
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
MLTX is expected to report earnings to rise 3.35% to -74 cents per share on May 08
Q1'25
Est.
$-0.74
Q4'24
Missed
by $0.12
Q3'24
Missed
by $0.12
Q2'24
Missed
by $0.11
Q1'24
Missed
by $0.02
The last earnings report on February 26 showed earnings per share of -72 cents, missing the estimate of -60 cents. With 318.77K shares outstanding, the current market capitalization sits at 2.30B.